| Sep'19 | Sep'18 | Sep'17 | Sep'16 | |||
|---|---|---|---|---|---|---|
Operating activities: | ||||||
Consolidated net income | ||||||
867 | 1,909 | 698 | -389 | |||
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | ||||||
Depreciation, depletion and amortization | ||||||
1,511 | 1,252 | 1,112 | 1,141 | |||
Cost of real estate sold | ||||||
17 | 121 | 207 | 87 | |||
Deferred income tax expense | ||||||
37 | -1,069 | -20 | -160 | |||
Share-based compensation expense | ||||||
64 | 66 | 58 | 75 | |||
Pension and other postretirement funding (more) than expense (income) | ||||||
61 | 96 | 51 | -275 | |||
Multiemployer pension withdrawals | ||||||
-6 | 184 | - | - | |||
Gain on sale of HH&B | ||||||
- | - | 192 | - | |||
Land and Development impairments | ||||||
13 | 31 | 46 | - | |||
Other impairment adjustments | ||||||
38 | 13 | 56 | 200 | |||
Gain on disposal of plant and equipment and other, net | ||||||
43 | -2 | 8 | - | |||
Impairment of Specialty Chemicals goodwill and intangibles | ||||||
- | - | - | 579 | |||
Other, net | ||||||
-80 | -96 | -87 | -87 | |||
Change in operating assets and liabilities, net of acquisitions and divestitures: | ||||||
Accounts receivable | ||||||
-272 | 580 | 520 | -36 | |||
Inventories | ||||||
110 | 72 | 48 | -50 | |||
Other assets | ||||||
124 | 67 | 44 | 92 | |||
Accounts payable | ||||||
-39 | 180 | 302 | -197 | |||
Income taxes | ||||||
7 | 130 | -67 | 73 | |||
Accrued liabilities and other | ||||||
-53 | 20 | 21 | 94 | |||
Net cash provided by operating activities | ||||||
2,310 | 1,931 | 1,463 | 1,688 | |||
Investing activities: | ||||||
Capital expenditures | ||||||
1,369 | 999 | 778 | 796 | |||
Cash paid related to business combinations, net of cash acquired | ||||||
3,374 | 239 | 1,588 | 376 | |||
Cash receipts on sold trade receivables | ||||||
- | 461 | 411 | - | |||
Debt purchased in connection with an acquisition | ||||||
- | - | - | 36 | |||
Investment in unconsolidated entities | ||||||
11 | 114 | 2 | 179 | |||
Proceeds from sale of HH&B | ||||||
- | - | 1,005 | - | |||
Proceeds from sale of property, plant and equipment | ||||||
119 | 23 | 52 | 31 | |||
Proceeds from property, plant and equipment insurance settlement | ||||||
25 | 7 | 3 | - | |||
Other, net | ||||||
-30 | -46 | -27 | -6 | |||
Net cash used for investing activities | ||||||
-4,579 | -815 | -868 | -1,351 | |||
Financing activities: | ||||||
Proceeds from issuance of notes | ||||||
2,498 | 1,197 | 998 | - | |||
(Repayments) additions to revolving credit facilities | ||||||
37 | -115 | 421 | 125 | |||
Additions to debt | ||||||
5,061 | 855 | 742 | 1,511 | |||
Repayments of debt | ||||||
5,631 | 2,032 | 2,331 | 1,073 | |||
(Repayments) additions to commercial paper, net | ||||||
339 | - | - | - | |||
Other financing (repayments) additions, net | ||||||
10 | -24 | 23 | 53 | |||
Specialty Chemicals spin-off of net cash and trust funding | ||||||
- | - | - | 105 | |||
Issuances of common stock, net of related minimum tax withholdings | ||||||
18 | 26 | 35 | 11 | |||
Purchases of common stock | ||||||
88 | 195 | 93 | 335 | |||
Cash dividends paid to stockholders | ||||||
467 | 440 | 403 | 380 | |||
Cash distributions paid to noncontrolling interests | ||||||
4 | 33 | 47 | 33 | |||
Other, net | ||||||
8 | 7 | -2 | -5 | |||
Net cash provided by financing activities | ||||||
1,780 | -755 | -655 | -231 | |||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||
4 | -28 | -2 | 6 | |||
Increase (decrease) in cash, cash equivalents and restricted cash | ||||||
-485 | 332 | -62 | 112 | |||
Supplemental disclosure of cash flow information: | ||||||
Income taxes, net of refunds | ||||||
226 | 60 | 227 | 157 | |||
Interest, net of amounts capitalized | ||||||
412 | 284 | 239 | 229 | |||